Consistent with the results of our in vitro study, enhanced expression of miR-200b or decreased expression of BMI1 in HCC cells significantly suppressed their tumorigenicity in vivo (Figure 3G; Figures S9 and S10). The gene discussed is BMI1; the disease is hepatocellular carcinoma.